Stock Market News — page 16

Markets stage a rapid rebound, with the S&P 500 rising sharply over a short span while dividend stocks resume outperformance amid steadier volatility, according to multiple outlets.

U.S. equities extended gains to fresh records amid solid earnings signals, while gold rose on China demand and Bitcoin paused near recent highs, underscoring mixed but resilient risk sentiment.

July ISM services index edged higher while subcomponents showed mixed readings, as traders weighed the data alongside the final composite PMI from S&P Global.

Arista Networks reports its first-ever $3 billion quarter, signaling strong demand for AI networking infrastructure amid broader tech market activity

Analysts say Advanced Micro Devices' shares could rebound after a post-earnings reversal, reinforcing a cautiously optimistic outlook despite an initial slide.

Disney shares rebound after reporting stronger-than-expected earnings, with the company pointing to Toy Story 5 as a driver of streaming and merchandise growth in the June quarter

Gran Tierra Energy agrees to divest its Colombian and Ecuadorian oil operations to Maurel & Prom for $1.3 billion, prompting a sharp rally in the company’s stock.

Asian equities climb as Wall Street’s strength and an AI-fueled tech rally propel gains, with SoftBank among notable movers in the region

Chipotle temporarily removed jalapeños from some locations after a Minnesota salmonella investigation, sparking a sharp stock reaction despite ongoing assurances of no current consumer health concerns.

Investors reacted to Bed Bath & Beyond’s performance signals ahead of its Q2 26 earnings call, with market attention focused on the retailer’s upcoming results and related corporate updates

Advanced Micro Devices broadens its AI initiatives through major partnerships, attracting investor attention amid market rumors of a stock surge

Chipotle faces a stock pullback after a Minnesota salmonella investigation prompts the removal of suspect jalapeños and a switch to peppers from other growers.

Merck posted a GAAP loss in the second quarter, while signaling a higher, yet narrower, full-year sales range as new drug sales contribute to revenue growth, but a charge tied to an acquisition weighs on profits.

Scotts Miracle-Gro shares rose after the company announced mid-range financial targets for fiscal 2027 through 2029, signaling a plan to drive sustainable value over the mid and long term.

The FTSE 100 rose modestly as mining shares led gains amid renewed hopes for U.S.-Iran diplomacy and a brighter risk appetite for equities.

Archer-Daniels-Midland reported a year-over-year increase in second-quarter profit, prompting a rally in its stock as markets digest the results

Italian tech group Bending Spoons agrees to buy Airtable in an all-cash deal valued near $1.29 billion

Toyota Motor Corp. posted higher quarterly net earnings on solid profitability despite weaker sales volume, upgraded its FY27 outlook, and announced a plan to buy back up to ¥1 trillion, with shares easing on the news.

Two major tech names crossed abrupt market-cap milestones after earnings and a momentum rally, highlighting the staying power of large-cap equities in global tech.

Amazon breaks into the $3 trillion club as AI-driven tools and cloud services propel investor enthusiasm and expand advertising revenue

Visa announced a cash deal to buy BioCatch, a behavioral-based fraud-detection firm, in a move to enhance its payments security offerings for merchants and digital transactions.

Across major tech players, funding methods for AI initiatives vary widely, with cash, debt, and partnerships shaping strategies as the market recalibrates.

Investors turn to SpaceX's first-ever earnings report, emphasizing Elon Musk's remarks and the potential for heightened trading volatility rather than the numbers alone.

Market speculation over potential AstraZeneca and Bristol Myers Squibb tie-up triggered divergent stock moves as investors weighed the prospects and scrutiny over a possible deal valued around $400 billion.

Market speculation over potential merger talks between AstraZeneca and Bristol Myers Squibb triggered a sharp split in the stocks of the two pharmaceutical giants, with Bristol Myers Squibb rising amid reports and AstraZeneca sliding on the same news cycle

Wall Street analysts highlight dividend-focused names as potential sources of passive income amid evolving sectors, with attention on NextEra Energy and smaller nuclear plays alongside broader growth stories.

Stocks of Perimeter Solutions fell as markets digested the company’s second-quarter 2026 results and related disclosures across outlets.

Investors betting against SpaceX ahead of earnings and a looming lockup expiration push into short positions, while Elon Musk contends short-sellers face very low survival probability, according to reports

Following a positive session close, Amazon's results and its AWS outperformance drew renewed analyst optimism, reinforcing expectations for continued stock-market strength

Colgate-Palmolive maintained its full-year sales outlook even as it reported weak profit in the second quarter, citing softness in North America but signaling higher adjusted earnings for FY26